Cognate BioServices, A Charles River Company

Cognate Therapeutics was formed to provide full commercialization support to emerging companies with varied cellular technologies, with similar challenges in manufacturing, development and delivery. The expertise of the management team and staff provides a cost-effective solution to the need in the current market for early focus on product development and clinical phase planning, without the need for extensive capital outlay. Cognate is also developing a pipeline of therapeutic product candidates using adult stem cells for cardiac, peripheral vascular and orthopedic indications.